Join us on Wednesday, May 15, 2024, in Chicago, IL or via live stream! Click below for more information and to register.

Chronic inflammatory diseases of the upper and lower airways, including allergic rhinitis, chronic rhinosinusitis with nasal polyps (CRSwNP), and asthma, have been tied to significant risks and burdens for affected patients. Although biologic therapies that target overactive cytokine signaling are available, newer therapies are emerging, with targets upstream in the pathogenic cascade to improve efficacy across both T2-high and T2-low profiles. Join us for this engaging Expert Roundtable™ to hear multidisciplinary insights related to pathophysiologic processes in chronic inflammatory airway diseases, the rationale and evidence behind new biologic therapies, and integrated therapeutic strategies to achieve global disease control.

For more information about the approval of this program, please contact Integritas at